Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Japan-based H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio have announced the availability of the Lu...
Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 c...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Palo Alto‑based PGxAI, a leader in AI-powered pharmacogenomics, and Saudi Arabia’s Novo Genomics ...
MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
South Korea based Alteogen Inc. has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. ...
D. Western Therapeutics Institute, Inc. (DWTI) has announced that Kowa Co., Ltd., to which DWTI out-licensed its in-hous...
US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to ...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...
US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Th...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...
Taiwan-based Foresee Pharmaceuticals has announced that Foresee Pharmaceuticals USA Inc., the company's fully-owned US s...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulti...
Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...
Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...
ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug...
